Startseite UR
![]() | Eine Stufe nach oben |
Zeman, Florian
, Giesinger, Johannes M., Pukrop, Tobias
, Petersen, Morten Aa, Groenvold, Mogens, Nolte, Sandra, Kuliś, Dagmara, Shrestha, Sunil, Leysen, Laurence, Cocks, Kim, Coens, Corneel, Ioannidis, Georgios, Pompili, Cecilia und Koller, Michael
(2025)
The EORTC QLQ-F17 as a shortened version of the EORTC QLQ-C30 to assess self-reported functioning in cancer patients: investigating equivalence and psychometric properties in a randomized cross-over trial.
eClinicalMedicine 84, S. 103262.
, Sprangers, Mirjam A.G., Brandberg, Yvonne
, Groenvold, Mogens, Flechtner, Hans-Henning
, Cocks, Kim, Velikova, Galina, Dirven, Linda
, Greimel, Elfriede, Singer, Susanne, Pogoda, Katarzyna
, Gamper, Eva M., Sodergren, Samantha C., Eggermont, Alexander, Koller, Michael, Reijneveld, Jaap C., Taphoorn, Martin J.B., King, Madeleine T. und Bottomley, Andrew
(2023)
Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types.
European Journal of Cancer 188, S. 171-182.
Volltext nicht vorhanden.
, Velikova, Galina, Flechtner, Hans-Henning und Bottomley, Andrew
(2022)
Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma – Interpretation guidance derived from two randomized EORTC trials.
Lung Cancer 167, S. 65-72.
Volltext nicht vorhanden.
, Quinten, Chantal, Reijneveld, Jaap C., Schürmann, Christoph, Smith, Ashley Wilder, Soltys, Katherine M., Sridhara, Rajeshwari, Taphoorn, Martin J. B., Velikova, Galina und Coens, Corneel
(2018)
Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials.
Clinical Trials 15 (6), S. 624-630.
Volltext nicht vorhanden.
, Quinten, Chantal, Reijneveld, Jaap C., Schürmann, Christoph, Smith, Ashley Wilder, Soltys, Katherine M., Taphoorn, Martin J. B., Velikova, Galina und Coens, Corneel
(2016)
Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards.
The Lancet Oncology 17 (11), e510-e514.
Volltext nicht vorhanden.
Publikationsserver
Publizieren: oa@ur.de
0941 943 -4239 oder -69394
Dissertationen: dissertationen@ur.de
0941 943 -3904
Forschungsdaten: datahub@ur.de
0941 943 -5707